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INTRODUCTION
The Tolosa-Hunt syndrome was first des-
cribed in 1954, in the case report of a patient with 
painful ophthalmoplegia caused by nonspecific 
granulomatous inflammation of the cavernous sinus 
and the cavernous portion of the internal carotid 
artery. Seven years later, Hunt published a series of 
six patients and proposed the criteria to diagnose 
the syndrome, as follows: 1 - acute retro-orbital 
pain; 2 - alterations on the third, fourth, sixth, or first 
branch of the fifth cranial nerve and, less commonly, 
involvement of the optic nerve or sympathetic fibers 
around the cavernous portion of the carotid; 3 - symp-
toms persisting for days or weeks; 4 - spontaneous 
pain remission; 5 - recurrent episodes; 6 - prompt 
response to steroids1,2.
Fifty-nine years after the description of 
this condition, the pathophysiological mechanisms 
and etiopathogenesis of the disease still remain 
controversial and obscure. This paper reports a case 
of Tolosa-Hunt syndrome in a patient first assumed 
to have a tumor in the cavernous sinus. Definitive 
diagnosis was obtained after a tumor was removed 
through endoscopic endonasal surgery.
CASE REPORT
M.A, 60, female, reported onset of right-side 
retro-orbital pain and hemifacial paresthesia six 
years ago after undergoing dental treatment. She 
took painkillers to no avail, and was hospitalized as 
ordered by a neurologist. The patient was dischar-
ged three days later with no pain and mild residual 
paresthesia. Four years later the patient presented 
right-side hemifacial paresthesia. She was seen by two 
different ENTs and was diagnosed with and treated 
for sinusopathy and labyrinthopathy. Five months 
later she developed right-side diplopia, and was once 
again hospitalized by the same team of neurologists. 
A skull MRI was ordered and she was diagnosed with 
a probable tumor in the cavernous sinus.
Our team was then called to assess the 
patient, and we opted to attempt to remove 
the tumor through an endoscopic endonasal 
procedure. The transsphenoidal approach was used 
to reach the cavernous sinus. Scissors were used 
to open the anterior wall of the sphenoid sinus 
following a line parallel to the middle concha. 
The posterolateral bone wall was removed with 
chisel and hammer to expose the cavernous sinus. 
Four landmarks were then meticulously identified: 
1 - the sphenoidal-orbital junction (anterior vertical 
boundary), 2 - the optic nerve (upper horizontal 
boundary), 3 - the maxillary branch (V2) of the 
trigeminal nerve (lower horizontal boundary), 
and 4 - the projection of the internal carotid artery 
(posterior vertical boundary). After the window was 
completed, the dura mater of the middle fossa was 
opened using three incisions: 1 - a horizontal incision, 
following a line below the projection of the optic 
nerve; 2 - a second horizontal incision, following 
a line above the projection of the maxillary nerve 
(V2); and 3 - a vertical incision, following a line in 
front of the most anterior projection of the internal 
carotid artery. The resulting flap was then lifted 
anteroposteriorly to reveal and allow access to the 
internal cavernous sinus.
The analysis of the specimen removed 
revealed nonspecific granulomatous inflammatory 
tissue. Immunohistochemistry assays (CD45, CD3, 
CD20, and CD30 to rule out lymphoma and other 
neoplasms) confirmed the diagnosis (Figure 1). 
Tolosa-Hunt syndrome was then considered and the 
patient was immediately put on high dose steroids. 
Two weeks into treatment the patient had improved 
significantly from pain, had no hemifacial pares-
thesia, and mild residual diplopia. The patient was 
asymptomatic after four weeks of treatment. Eight 
months after the end of drug therapy, the patient 
showed no signs of recurrence.
DISCUSSION
The Tolosa-Hunt syndrome is a painful 
ophthalmoplegia characterized by unilateral orbital pain 
and oculomotor paresis that responds immediately to 
steroid therapy3. In 1988, the International Headache 
Society included the Tolosa-Hunt syndrome in the list of 
cranial neuralgias and, in 2004, the classification criteria 
for the syndrome were defined. Differential diagnosis 
includes diabetic neuropathy, cavernous sinus throm-
bophlebitis, ophthalmoplegic migraine, and tumors4,5. 
Given the nonspecific nature of the disease’s clinical 
findings, imaging and pathology testing can be used 
to accurately diagnose the syndrome.
Endoscopic surgery offers a safe and viable 
way to access the cavernous sinus when performed 
by properly trained personnel. The procedure 
does not require external approaches such as large 
craniotomies, and stands out as a less invasive and 
nearly atraumatic treatment option, in addition to 
shortening patient recovery time after surgery. The 
literature shows that treatment is based on clinical and 
radiological findings and does not include histology 
testing, a possibly valuable resource to that end.
CLOSING REMARKS
The Tolosa-Hunt syndrome is a rare disease 
of unknown etiopathogenesis. The absence of a spe-
cific biologic marker for the syndrome requires the 
ruling out of all other causes of painful ophthalmo-
plegia, specifically when the patient is suspected for 
malignant disease, as in the case reported in this paper. 
Endoscopic endonasal surgery can be safely used to 
access the cavernous sinus and gather specimens for 
histology testing. Additionally, the procedure plays a 
fundamental role in the choice of treatment for patients 
with clinical or radiological signs of this disease.
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Figure 1. A: Preoperative skull MRI (contrast-enhanced T1). The 
arrow points to an expansive mass in the right cavernous sinus; B: 
Postoperative skull MRI (contrast-enhanced T1). The arrow points 
to the right cavernous sinus now without the mass.
